首页> 美国卫生研究院文献>Clinical Molecular Pathology >Expression of CD15 antigen in urinary bladder transitional cell carcinoma.
【2h】

Expression of CD15 antigen in urinary bladder transitional cell carcinoma.

机译:CD15抗原在膀胱移行细胞癌中的表达。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The biopsy specimens of 91 patients between the ages of 38 and 94 with transitional cell carcinoma of the bladder were retrospectively reviewed to determine if the expression of CD15 antigen detected by a monoclonal antibody MC2 was correlated with prognosis. Expression was variable, ranging from strong expression of the antigen by only the superficial cells in well differentiated papillary lesions to weak expression by most cells in solid or invasive tumours. In the invasive component there was a correlation between MC2 expression and tumour type, suggesting that the cell surface carbohydrate detected by MC2 may have a role in cell adhesion. There was no correlation between staining and survival. It is concluded that tumour type, grade, and stage remain the best prognostic indicators of urothelial tumours.
机译:回顾性分析了91例年龄在38至94岁之间的膀胱移行细胞癌患者的活检标本,以确定单克隆抗体MC2检测到的CD15抗原的表达是否与预后相关。表达是可变的,范围从仅在分化良好的乳头状病变中仅表层细胞强烈表达抗原到在实体瘤或浸润性肿瘤中大多数细胞的弱表达。在侵袭性成分中,MC2表达与肿瘤类型之间存在相关性,表明MC2检测到的细胞表面碳水化合物可能在细胞粘附中起作用。染色与存活之间没有相关性。结论是,肿瘤类型,分级和分期仍然是尿路上皮肿瘤的最佳预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号